FDA Stresses Stability In Wake Of Commissioner’s Resignation
This article was originally published in The Rose Sheet
Executive Summary
FDA leadership is telling agency staff that operations will not be disrupted by the departure of Commissioner Lester Crawford after just two months in the permanent position